Published in Clinical Trials Week, April 5th, 2004
"We are pleased to have reached this major milestone," said Natalie Dakers, president and CEO. "The commencement of our phase I clinical trial represents a significant step forward in providing a much-needed alternative to chronic pain management able to bring relief to the millions of people suffering severe, chronic, and neuropathic pain."
The initial phase I trial will consist of a single-center, double-blind, randomized,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.